+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease



Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease



Hong Kong Medical Journal 20(Suppl. 4): 18-21




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055993014

Download citation: RISBibTeXText

PMID: 25224113


Related references

Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease. Antiviral Research 92(2): 204-212, 2011

Profiling of substrate-specificity and rational design of broad-spectrum peptidomimetic inhibitors for main proteases of coronaviruses. Hong Kong Medical Journal 20(Suppl. 4): 22-25, 2014

An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors. Chembiochem 7(7): 1048-1055, 2006

Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease. Biophysical Journal 98(7): 1327-1336, 2010

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochemistry 43(17): 4906-4912, 2004

Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. Biochemistry 46(30): 8744-8752, 2007

Inhibitor Design for Sars Coronavirus Main Protease Based on Distorted Key Theory. Medicinal Chemistry 3(1): 1-6, 2007

Inhibitor design for SARS coronavirus main protease based on "distorted key theory". Medicinal Chemistry ) 3(1): 1-6, 2007

Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease. Bioorganic and Medicinal Chemistry 24(6): 1241-1254, 2016

Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design. Chemical & Pharmaceutical Bulletin 52(5): 643-645, 2004

Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere. Biopolymers 40(2): 235-244, 1996

Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design. Bioorganic and Medicinal Chemistry 12(9): 2219-2223, 2004

Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Science 15(4): 699-709, 2006

Characterization and Inhibition of Sars-Coronavirus Main Protease. Current Topics in Medicinal Chemistry 6(4): 361-376, 2006

Characterization and inhibition of SARS-coronavirus main protease. Current Topics in Medicinal Chemistry 6(4): 361-376, 2006